Lee Phoebe L, Ma Irene T, Schusterman Mark Asher, Beiriger Justin, Ahrendt Gretchen, De La Cruz Carolyn, Diego Emilia J, Steiman Jennifer G, McAuliffe Priscilla F, Gimbel Michael L
University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Department of Plastic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.
Plast Reconstr Surg Glob Open. 2023 Jan 20;11(1):e4783. doi: 10.1097/GOX.0000000000004783. eCollection 2023 Jan.
Necrosis of the nipple-areolar complex (NAC) or surrounding skin has been reported in 6%-30% of nipple-sparing mastectomy (NSM) patients, with higher rates associated with larger breasts, previous breast surgery, previous radiation, and active smoking. The nipple delay (ND) procedure is known to improve viability of the NAC in NSM patients with high-risk factors.
A single-institution retrospective review was done of patients who underwent ND and NSM or NSM alone from 2012 to 2022. Patient demographics, risk factors, and outcomes were compared.
Forty-two breasts received ND-NSM and 302 breasts received NSM alone. The ND-NSM group had significantly more high-risk factors, including elevated BMI (26.3 versus 22.9; < 0.001), elevated prior breast surgery (50% versus 25%; < 0.001), and greater mastectomy specimen weight (646.6 versus 303.2 g; < 0.001). ND-NSM was more likely to have undergone preparatory mammoplasty before NSM (27% versus 1%; < 0.001). There was no delay in NSM treatment from decision to pursue NSM ( = 0.483) or difference in skin necrosis ( = 0.256), NAC necrosis ( = 0.510), hematoma ( = 0.094), seroma ( = 0.137), or infection ( = 0.437) between groups. ND-NSM and NSM patients differed in total NAC necrosis (0% versus 3%) and implant loss (0% vs 13%), but not significantly.
We demonstrated no NAC necrosis and no significant delay of treatment in higher risk ND-NSM patients. ND may allow higher risk patients to undergo NSM with similar morbidity as lower risk patients.
据报道,在保留乳头的乳房切除术(NSM)患者中,乳头乳晕复合体(NAC)或周围皮肤坏死的发生率为6% - 30%,乳房较大、既往有乳房手术史、既往接受过放疗以及当前吸烟的患者发生率更高。乳头延迟(ND)手术已知可提高具有高危因素的NSM患者中NAC的存活能力。
对2012年至2022年期间接受ND和NSM或仅接受NSM的患者进行了单机构回顾性研究。比较了患者的人口统计学特征、危险因素和结果。
42例乳房接受了ND - NSM,302例乳房仅接受了NSM。ND - NSM组的高危因素明显更多,包括体重指数升高(26.3对22.9;<0.001)、既往乳房手术史增加(50%对25%;<0.001)以及乳房切除标本重量更大(646.6对303.2克;<0.001)。ND - NSM患者在NSM前更有可能接受过预备性乳房整形术(27%对1%;<0.001)。从决定进行NSM到NSM治疗没有延迟(=0.483),两组之间在皮肤坏死(=0.256)、NAC坏死(=0.510)、血肿(=0.094)、血清肿(=0.137)或感染(=0.437)方面没有差异。ND - NSM和NSM患者在总的NAC坏死(0%对3%)和植入物丢失(0%对13%)方面存在差异,但不显著。
我们证明,在高危的ND - NSM患者中没有NAC坏死且治疗没有明显延迟。ND可能使高危患者能够接受NSM,其发病率与低危患者相似。